Maha FDA Sampling Finds 5% Meds Substandard

Mumbai:  Nearly 5% of medicines sold at city’s pharmacies have been found to be of sub-standard by the Food And Drug Administration (FDA). A case has also been registered against drug manufacturers for selling substandard medicines, which can adversely affect citizens’ health.

As per FDA data, 2,530 medicines samples were collected from April to October across Mumbai, of which 124 were found to be sub-standard. “Every month, samples of seven medicines are taken from drug stores and sent to laboratory testing. Of these, about 2,000 samples of allopathy, 415 of ayurveda and homeopathy medicines were taken,” said an FDA official.

During the financial year 2019-20 (660 out of 8378 samples), 2020-21 (464 out of 7632), 2021-22 (364 out of 5146) and 2022-23 (468 out of 12790) found sub-standard.

FDA Drug Joint Commissioner Bhushan Patil said they continuously collect and test random samples at their labs in Mumbai, Nagpur and Sambhajinagar. “A case is registered in the court against pharmaceutical companies that fail to meet the quality standards, following which their manufacturing license is suspended or cancelled,” he said.

  • Related Posts

    • Pharma
    • July 24, 2025
    • 78 views
    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

    • Pharma
    • July 22, 2025
    • 174 views
    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra